Enzyme‐Catalyzed Formation of Supramolecular Hydrogels as Promising Vaccine Adjuvants
- 3 February 2016
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 26 (11) , 1822-1829
Abstract
Promising vaccine adjuvants of self‐assembling peptide hydrogels for protein ovalbumin (OVA) are introduced in this study. The hydrogels are formed by the enzyme of phosphatase, and the vaccine adjuvant potency of both l‐ and d‐peptide hydrogels is evaluated. The results indicate that, compared with the clinically used alum adjuvant, both l‐ and d‐peptide hydrogels can increase the IgG production of OVA for about 1.3 and 3.8 times, respectively. Both gels can enhance antigen uptake and induce dendritic cell maturation, and promote and prolong accumulation of antigen in lymph node, as well as evoke germinal center formation. However, the d‐peptide hydrogel with OVA exhibits a slightly more efficient accumulation of OVA in the lymph nodes and seems preventing tumor growth more significantly than its l‐counterpart. With the good biocompatibility and degradability of peptide hydrogels, the hydrogels described in this study have big potential for the production of protein vaccines for immunotherapy against different diseases.Keywords
Funding Information
- International S&T Cooperation Program of China (2015DFA50310)
- National Natural Science Foundation of China (51373079, 51403159)
This publication has 78 references indexed in Scilit:
- The effect of protein structure on their controlled release from an injectable peptide hydrogelBiomaterials, 2010
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Multi-component extracellular matrices based on peptide self-assemblyChemical Society Reviews, 2010
- A self-assembly pathway to aligned monodomain gelsNature Materials, 2010
- Self-Assembling Multidomain Peptide Hydrogels: Designed Susceptibility to Enzymatic Cleavage Allows Enhanced Cell Migration and SpreadingJournal of the American Chemical Society, 2010
- A self-assembling peptide acting as an immune adjuvantProceedings of the National Academy of Sciences, 2009
- Toll-Like Receptor 3 Ligand and Retinoic Acid Enhance Germinal Center Formation and Increase the Tetanus Toxoid Vaccine ResponseClinical and Vaccine Immunology, 2009
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Co-assembling peptides as defined matrices for endothelial cellsBiomaterials, 2009
- Mechanism of action of clinically approved adjuvantsCurrent Opinion in Immunology, 2009